Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
04/24/20247:03AMPR Newswire (US)Coast survey finds construction companies have significant gaps in their field expense management practices
04/24/20247:03AMPR Newswire (US)Too Much Acid in Your Diet: It's Probably Your Coffee
04/24/20247:03AMPR Newswire (US)Taylor Morrison Opens One of The Final New Build Communities in the Arvada MarketNYSE:TMHCTaylor Morrison Home Holding Company
04/24/20247:02AMAlliance NewsAlliance NewsEXTRA: Warpaint boosts annual earnings as consumers stick by cosmeticsLSE:W7LWarpaint London Plc
04/24/20247:01AMPR Newswire (US)Travelzoo Reports First Quarter 2024 ResultsNASDAQ:TZOOTravelzoo
04/24/20247:01AMGlobeNewswire Inc.HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated CancersNASDAQ:HOOKHOOKIPA Pharma Inc
04/24/20247:00AMGlobeNewswire Inc.Rogers Communications Reports First Quarter 2024 ResultsRCI-B
04/24/20247:00AMGlobeNewswire Inc.Rogers Communications Reports First Quarter 2024 ResultsNYSE:RCIRogers Communications Inc
04/24/20247:00AMGlobeNewswire Inc.Rogers Communications Reports First Quarter 2024 ResultsRCI-A
04/24/20247:00AMGlobeNewswire Inc.Shenandoah Telecommunications Company to Hold its First Quarter 2024 Earnings Call at 8:30 a.m. on Friday, May 3, 2024NASDAQ:SHENShenandoah Telecommunications Company
04/24/20247:00AMGlobeNewswire Inc.Smart Share Global Limited Files Its Annual Report on Form 20-FNASDAQ:EMSmart Share Global Limited
04/24/20247:00AMGlobeNewswire Inc.atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant DepressionNASDAQ:ATAIATAI Life Sciences NV
04/24/20247:00AMGlobeNewswire Inc.Alts Marketplace Unveils Latest Developments in Alternative Investments
04/24/20247:00AMGlobeNewswire Inc.Rogers Communications Declares 50 Cents per Share Quarterly DividendNYSE:RCIRogers Communications Inc
04/24/20247:00AMGlobeNewswire Inc.Rogers Communications Declares 50 Cents per Share Quarterly DividendRCI-A
04/24/20247:00AMGlobeNewswire Inc.Rogers Communications Declares 50 Cents per Share Quarterly DividendRCI-B
04/24/20247:00AMBusiness WireAirspeed Launches Culture Graph to Help Companies Measure the Cultural Health of Their Organization
04/24/20247:00AMGlobeNewswire Inc.Media Advisory: Day of Mourning 2024 - CLC Secretary-Treasurer Lily Chang to attend Saint John event
04/24/20247:00AMGlobeNewswire Inc.Satellite Applications Catapult trials Arqit Network Secure™NASDAQ:ARQQWArqit Quantum Inc
04/24/20247:00AMGlobeNewswire Inc.Crosschq Launches Insights, First-of-its-Kind Recruiting Analytics and Quality of Hire Engine
04/24/20247:00AMGlobeNewswire Inc.Alta Equipment Group Announces Date of First Quarter 2024 Financial Results Release, Conference Call and WebcastNYSE:ALTGAlta Equipment Group Inc
04/24/20247:00AMGlobeNewswire Inc.Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024NASDAQ:CMRXChimerix Inc
04/24/20247:00AMGlobeNewswire Inc.Matrix Service Company Sets Dates for Release of Third Quarter Fiscal 2024 Financial Results and Conference CallNASDAQ:MTRXMatrix Service Co
04/24/20247:00AMGlobeNewswire Inc.Genius Group Appoints Alan Turing AI as Chief AI OfficerAMEX:GNSGenius Group Limited
04/24/20247:00AMGlobeNewswire Inc.Aduro Clean Technologies Joins Delegation at Intergovernmental Negotiating Committee on Plastic Pollution (INC-4)TG:9D50Aduro Clean Technologies Inc
04/24/20247:00AMGlobeNewswire Inc.Satellite Applications Catapult trials Arqit Network Secure™NASDAQ:ARQQArqit Quantum Inc
04/24/20247:00AMGlobeNewswire Inc.GXO Releases Preliminary First Quarter 2024 ResultsTG:93NGXO Logistics
04/24/20247:00AMBusiness WireHCSG Reports Q1 2024 ResultsNASDAQ:HCSGHealthcare Services Group Inc
04/24/20247:00AMGlobeNewswire Inc.Satellite Applications Catapult trials Arqit Network Secure™
04/24/20247:00AMGlobeNewswire Inc.Biolojic Design Announces that Nektar Therapeutics Has Exercised Its License Option to Develop an AI-Designed Agonistic Antibody Targeting TNFR2 for the Treatment of Autoimmune Diseases